PillRx only · Injection, Solution · Subcutaneous
Icatibant
Icatibant Acetate
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
317
Rx · 2026 Q1
4.0K
Units dispensed
-3%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | unknown | 2 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 2 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 2 | SUPPLYING |
| Eugia US LLC | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- May 7, 2026RESOLVEDShortage resolved: Icatibant Acetate Injection (Fresenius Kabi USA, LLC)
Icatibant Acetate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Hematology.
- May 7, 2026SHORTAGEDrug shortage: Icatibant Acetate Injection (Fresenius Kabi USA, LLC)
Icatibant Acetate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Hematology.